SMT201600059B - Trattamento di infezioni da streptococco - Google Patents

Trattamento di infezioni da streptococco

Info

Publication number
SMT201600059B
SMT201600059B SM201600059T SM201600059T SMT201600059B SM T201600059 B SMT201600059 B SM T201600059B SM 201600059 T SM201600059 T SM 201600059T SM 201600059 T SM201600059 T SM 201600059T SM T201600059 B SMT201600059 B SM T201600059B
Authority
SM
San Marino
Prior art keywords
streptococco
infections
treatment
streptococco infections
Prior art date
Application number
SM201600059T
Other languages
English (en)
Inventor
Philippe Denoel
Philippe Vincent Hermand
Steve Labbe
Jan Poolman
Stephane Rioux
Original Assignee
Glaxosmith Kline Biolog S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmith Kline Biolog S A filed Critical Glaxosmith Kline Biolog S A
Publication of SMT201600059B publication Critical patent/SMT201600059B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SM201600059T 2010-03-09 2016-02-25 Trattamento di infezioni da streptococco SMT201600059B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1003920.4A GB201003920D0 (en) 2010-03-09 2010-03-09 Method of treatment
PCT/EP2011/053485 WO2011110570A1 (en) 2010-03-09 2011-03-08 Treatment of streptococcal infections

Publications (1)

Publication Number Publication Date
SMT201600059B true SMT201600059B (it) 2016-04-29

Family

ID=42136723

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201600059T SMT201600059B (it) 2010-03-09 2016-02-25 Trattamento di infezioni da streptococco

Country Status (24)

Country Link
US (2) US20120328659A1 (it)
EP (1) EP2544711B1 (it)
JP (1) JP5968229B2 (it)
KR (1) KR20130038237A (it)
CN (1) CN102869376A (it)
AU (1) AU2011226119B2 (it)
BR (1) BR112012022360A2 (it)
CA (1) CA2791946A1 (it)
CY (1) CY1117238T1 (it)
DK (1) DK2544711T3 (it)
EA (1) EA023702B1 (it)
ES (1) ES2562979T3 (it)
GB (1) GB201003920D0 (it)
HR (1) HRP20160150T1 (it)
HU (1) HUE027103T2 (it)
MX (1) MX2012010386A (it)
PL (1) PL2544711T3 (it)
PT (1) PT2544711E (it)
RS (1) RS54593B1 (it)
SG (1) SG183474A1 (it)
SI (1) SI2544711T1 (it)
SM (1) SMT201600059B (it)
WO (1) WO2011110570A1 (it)
ZA (1) ZA201206636B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60134494D1 (de) * 2000-12-21 2008-07-31 Id Biomedical Corp Antigene aus streptococcus pyogenes und zugehörige dna-fragmente
US20160228500A9 (en) * 2007-07-23 2016-08-11 Martina Ochs Immunogenic Polypeptides and Monoclonal Antibodies
US20140193451A1 (en) * 2012-10-17 2014-07-10 Glaxosmithkline Biologicals Sa Immunogenic composition
CN105441319A (zh) * 2015-07-29 2016-03-30 东莞东华医院有限公司 一种围产期孕妇b群链球菌采样管及其制备方法
MY199342A (en) 2016-08-05 2023-10-24 Sanofi Pasteur Inc Multivalent pneumococcal polysaccharide-protein conjugate composition
KR102437120B1 (ko) 2016-08-05 2022-08-25 사노피 파스퇴르 인코포레이티드 다가 폐렴구균 다당류-단백질 접합체 조성물
SG11202006387QA (en) 2018-02-05 2020-07-29 Sanofi Pasteur Inc Multivalent pneumococcal polysaccharide-protein conjugate composition
KR102486891B1 (ko) 2018-02-05 2023-01-10 사노피 파스퇴르 인코포레이티드 다가 폐렴구균성 다당류-단백질 접합체 조성물
KR20190121713A (ko) 2018-04-18 2019-10-28 에스케이바이오사이언스(주) 스트렙토코커스 뉴모니애 협막 다당류 및 그의 면역원성 접합체

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235877A (en) 1979-06-27 1980-11-25 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4940460A (en) 1987-06-19 1990-07-10 Bioject, Inc. Patient-fillable and non-invasive hypodermic injection device assembly
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US5339163A (en) 1988-03-16 1994-08-16 Canon Kabushiki Kaisha Automatic exposure control device using plural image plane detection areas
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
JPH0832638B2 (ja) 1989-05-25 1996-03-29 カイロン コーポレイション サブミクロン油滴乳剤を含んで成るアジュバント製剤
FR2649013B1 (fr) 1989-07-03 1991-10-25 Seppic Sa Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable
FR2649012B1 (fr) 1989-07-03 1991-10-25 Seppic Sa Emulsions multiphasiques injectables
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
GB9118204D0 (en) 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
NZ253137A (en) 1992-06-25 1996-08-27 Smithkline Beecham Biolog Vaccine comprising antigen and/or antigenic composition, qs21 (quillaja saponaria molina extract) and 3 de-o-acylated monophosphoryl lipid a.
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
US5569189A (en) 1992-09-28 1996-10-29 Equidyne Systems, Inc. hypodermic jet injector
US5334144A (en) 1992-10-30 1994-08-02 Becton, Dickinson And Company Single use disposable needleless injector
EP0689454B2 (en) 1993-03-23 2005-02-23 SMITHKLINE BEECHAM BIOLOGICALS s.a. Vaccine compositions containing 3-o deacylated monophosphoryl lipid a
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
WO1995024176A1 (en) 1994-03-07 1995-09-14 Bioject, Inc. Ampule filling device
US5466220A (en) 1994-03-08 1995-11-14 Bioject, Inc. Drug vial mixing and transfer device
DE69535905D1 (de) 1994-07-15 2009-02-26 Coley Pharm Group Inc Immunomodulatorische Oligonukleotide
US5599302A (en) 1995-01-09 1997-02-04 Medi-Ject Corporation Medical injection system and method, gas spring thereof and launching device using gas spring
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
US5730723A (en) 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
US5893397A (en) 1996-01-12 1999-04-13 Bioject Inc. Medication vial/syringe liquid-transfer apparatus
GB9607549D0 (en) 1996-04-11 1996-06-12 Weston Medical Ltd Spring-powered dispensing device
DK0914178T3 (da) 1996-06-18 2003-04-22 Alza Corp Anordning til forøgelse af transdermal afgivelse eller prøveudtagning af et middel
PT942983E (pt) 1996-10-31 2007-02-28 Human Genome Sciences Inc Antigénios e vacinas de streptococcus pneumoniae
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
ATE234649T1 (de) 1996-12-20 2003-04-15 Alza Corp Vorrichtung und verfahren zur erhöhung des transdermalen wirkstoffeflusses
US5993412A (en) 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
GB9711990D0 (en) 1997-06-11 1997-08-06 Smithkline Beecham Biolog Vaccine
CA2302554C (en) 1997-09-05 2007-04-10 Smithkline Beecham Biologicals S.A. Oil in water emulsions containing saponins
GB9718901D0 (en) 1997-09-05 1997-11-12 Smithkline Beecham Biolog Vaccine
BR9812525A (pt) 1997-09-24 2000-07-25 Univ Minnesota Proteinase degradadora de complemento humano c3 de streptococcus pneumoniae
WO1999027961A1 (en) 1997-12-02 1999-06-10 Powderject Vaccines, Inc. Transdermal delivery of particulate vaccine compositions
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
IL142017A0 (en) 1998-09-24 2002-03-10 Univ Minnesota Human complement c3-degrading polypeptide from streptococcus pneumoniae
WO2000030299A1 (en) 1998-11-17 2000-05-25 Schlumberger Technology Corporation Transmitting information over a communication link
DK1140157T3 (da) * 1998-12-21 2009-06-08 Medimmune Inc Streptococcus pneumoniae-proteiner og immunogene fragmenter til vacciner
WO2000039299A2 (en) * 1998-12-23 2000-07-06 Shire Biochem Inc. Streptococcus antigens
US6319224B1 (en) 1999-08-20 2001-11-20 Bioject Medical Technologies Inc. Intradermal injection system for injecting DNA-based injectables into humans
JP4749641B2 (ja) * 1999-08-25 2011-08-17 メディミューン，エルエルシー ワクチン用の肺炎球菌タンパク質の相同体および断片
US6494865B1 (en) 1999-10-14 2002-12-17 Becton Dickinson And Company Intradermal delivery device including a needle assembly
CZ2003154A3 (cs) * 2000-06-20 2003-06-18 Shire Biochem Inc. Antigeny streptokoka
EP1186299A1 (en) * 2000-09-12 2002-03-13 Universitair Medisch Centrum Utrecht The diagnosis, prevention, and/or succesful treatment of atherosclerosis, infectious diseases, and disturbances in the immune system
JP5442173B2 (ja) * 2000-09-14 2014-03-12 敏一 中村 筋萎縮性側索硬化症治療剤
ATE438409T1 (de) * 2000-09-15 2009-08-15 Pasteur Institut Proteinhaltigen vektoren zur einführung von moleküle in cd11b exprimirende zellen
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
JP2004509970A (ja) 2000-09-26 2004-04-02 ハイブリドン・インコーポレイテッド 位置的化学変化による免疫刺激オリゴヌクレオチドアナログの免疫刺激活性の調節
WO2003050782A1 (en) 2001-12-12 2003-06-19 Hogakukan Co., Ltd. Exercise setting system
AU2002351623A1 (en) * 2001-12-20 2003-07-09 Shire Biochem Inc. Streptococcus antigens
WO2005107798A1 (en) 2004-05-11 2005-11-17 De Staat Der Nederlanden, Vertegenwoordigd Door De Minister Van Vws NEISSERIA MENINGITIDIS IgtB LOS AS ADJUVANT
CN100433358C (zh) * 2005-12-22 2008-11-12 友达光电股份有限公司 双面显示装置
US8337846B2 (en) * 2007-07-23 2012-12-25 Sanofi Pasteur Limited Immunogenic polypeptides and monoclonal antibodies

Also Published As

Publication number Publication date
JP5968229B2 (ja) 2016-08-10
RS54593B1 (sr) 2016-08-31
AU2011226119B2 (en) 2014-04-24
AU2011226119A1 (en) 2012-11-01
SI2544711T1 (sl) 2016-03-31
WO2011110570A1 (en) 2011-09-15
ES2562979T3 (es) 2016-03-09
PL2544711T3 (pl) 2016-06-30
US20120328659A1 (en) 2012-12-27
US20140205634A1 (en) 2014-07-24
ZA201206636B (en) 2014-02-26
DK2544711T3 (en) 2016-03-07
CN102869376A (zh) 2013-01-09
KR20130038237A (ko) 2013-04-17
CY1117238T1 (el) 2017-04-05
EA023702B1 (ru) 2016-07-29
EA201290689A1 (ru) 2013-08-30
JP2013521322A (ja) 2013-06-10
GB201003920D0 (en) 2010-04-21
US9314518B2 (en) 2016-04-19
PT2544711E (pt) 2016-03-22
MX2012010386A (es) 2012-10-10
CA2791946A1 (en) 2011-09-15
EP2544711B1 (en) 2016-01-06
HUE027103T2 (en) 2016-08-29
EP2544711A1 (en) 2013-01-16
BR112012022360A2 (pt) 2019-09-24
SG183474A1 (en) 2012-09-27
HRP20160150T1 (en) 2016-03-11

Similar Documents

Publication Publication Date Title
HUE059033T2 (hu) Benzoxaborol-származékok bakteriális fertõzések kezelésére
EP2723384A4 (en) TREATMENT OF PROTEINOPATHIES
SMT201600370B (it) Complessi chelati di oligonucleotidi
PT2640375T (pt) Método de tratamento da nefropatia induzida por contraste
HUE048876T2 (hu) Rákos megbetegedések kezelése
PL2739153T3 (pl) Leczenie raka sutka
LT3222272T (lt) Farmacinė karbetocino kompozicija
HRP20180972T1 (hr) Kombinacija fenoksibenzamina i polimiksina e za liječenje mikrobnih infekcija
SMT201600059B (it) Trattamento di infezioni da streptococco
PL2696890T3 (pl) Leczenie infekcji drobnoustrojowych
EP2555765A4 (en) TREATMENT OF LOUIS BAR SYNDROME
ITTO20110641A1 (it) Composizioni farmaceutiche e metodi di trattamento
IL235130A0 (en) Compositions for topical treatment of microbial infections
PT2750709T (pt) Tratamento da caquexia
BRPI1014688A2 (pt) aplicações terapêuticas de derivados de quinazolinadiona
PL2658531T3 (pl) Zastosowanie stabilizatorów glutamidowych
EP2611440A4 (en) TREATMENT OF COCAINE
EP2576582A4 (en) TREATMENT OF MUSCLE DYSTROPHY
ITTO20110268A1 (it) Composizione di maquillage.
IT1398549B1 (it) Silil- derivati di polisaccaridi
IT1392635B1 (it) Trattamento ematico di ozonoterapia
SMT201600196B (it) Trattamento con porfirina di patologie neurodegenerative
PT2431030E (pt) Tratamento de infeções fúngicas
FR2955136B1 (fr) Arret de vantail
EP2440238A4 (en) Methods of Treatment